Patients will be able to access Eli Lilly's weight-loss drug Zepbound at Walmart pharmacies nationwide through its direct-to-consumer program as soon as next month.
The partnership between Eli Lilly and Company and Walmart, announced Wednesday, will allow people with a valid prescription to pick up single-dose vials of Zepbound at Walmart pharmacies nationwide or opt for home delivery. Both are enabled through Eli Lilly's direct-to-consumer platform, LillyDirect.
Lily's direct-to-consumer platform, which launched in early 2024, is the company's solution to improve the affordability and availability of the blockbuster drug because it allows some consumers to buy medicines directly from Eli Lilly without going through insurance.
The company said that LillyDirect offers savings of 50% or

FOX Business
People Human Interest
KCCI 8
Raw Story
AlterNet
Verywell Health
Reuters US Top
AZ BIG Media Economy
KSL Utah
The List